Wakamoto Pharmaceutical Co.,Ltd.

TSE:4512 Stock Report

Market Cap: JP¥8.0b

Wakamoto PharmaceuticalLtd Management

Management criteria checks 1/4

Wakamoto PharmaceuticalLtd's CEO is Arata Igarashi, appointed in Apr 2022, has a tenure of 2.08 years. directly owns 0.14% of the company’s shares, worth ¥10.99M. The average tenure of the management team and the board of directors is 1.9 years and 6.9 years respectively.

Key information

Arata Igarashi

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.1yrs
CEO ownership0.1%
Management average tenure1.9yrs
Board average tenure6.9yrs

Recent management updates

Recent updates


CEO

Arata Igarashi (65 yo)

2.1yrs

Tenure

Mr. Arata Igarashi serves as President at Wakamoto Pharmaceutical Co.,Ltd since April 2022 and serves as its Chairman. He had been Senior Managing Director and General Manager of Administration Headquarter...


Leadership Team

NamePositionTenureCompensationOwnership
Arata Igarashi
President & Chairman2.1yrsno data0.14%
¥ 11.0m
Kimihiko Sato
GM of Administration Division2.1yrsno data0.066%
¥ 5.3m
Kazuhiko Fukuhara
Head of Public Relations Officeno datano datano data
Takehiko Tanigaki
GM of Global Business Division & Sales Planning Department and Director1.9yrsno data0.055%
¥ 4.4m
Hiroyoshi Kasai
GM of Pharmaceutical Development Division & Product Strategy Department and Director1.9yrsno data0.032%
¥ 2.5m
Noboru Yamazaki
Senior Executive Officer1.3yrsno datano data
Mizuho Koike
Operating Officer1.3yrsno datano data

1.9yrs

Average Tenure

63yo

Average Age

Experienced Management: 4512's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Arata Igarashi
President & Chairman12.9yrsno data0.14%
¥ 11.0m
Kimihiko Sato
GM of Administration Division9.9yrsno data0.066%
¥ 5.3m
Takehiko Tanigaki
GM of Global Business Division & Sales Planning Department and Director1.9yrsno data0.055%
¥ 4.4m
Hiroyoshi Kasai
GM of Pharmaceutical Development Division & Product Strategy Department and Director1.9yrsno data0.032%
¥ 2.5m
Katsuyoshi Ejima
Outside Independent Director6.9yrsno datano data
Haruhisa Hirata
Director14.9yrsno data0.20%
¥ 16.0m
Ikuro Kuwahara
Independent Outside Directorless than a yearno datano data

6.9yrs

Average Tenure

65yo

Average Age

Experienced Board: 4512's board of directors are considered experienced (6.9 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.